As Expected, Quest Diagnostics Posts 2 Percent Sales Decline | GenomeWeb

NEW YORK (GenomeWeb News) – Quest Diagnostics today reported that its third quarter sales were down 2 percent year over year, in line with its pre-announcement made just last week.

The clinical lab and diagnostic information services provider reported revenues of $1.79 billion for the three months ended Sept. 30, down 2 percent year over year from $1.82 billion. Analysts had previously expected $1.84 billion in revenues for the quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.